BOOK-CHAPTER

Drug Repurposing for COVID-19 using Computational Methods

Abstract

In this chapter, we use computational methods to illustrate drug repurposing with the example of COVID-19. Here, the current status of drug discovery has been described with various aspects of drug repurposing interactions, use of algorithms in drug repurposing, re-evaluation of existing drugs, challenges in drug repurposing, and biological and computational interpretation of personalised and AI-guided repurposing. In addition, we present blueprints for pacing up the drug repurposing process using artificial intelligence. This chapter is devoted to the use of computational intelligence for drug repurposing against various diseases, including COVID-19.<br>

Keywords:
Drug repositioning Repurposing Computer science Drug Coronavirus disease 2019 (COVID-19) Blueprint Drug discovery Benchmark (surveying) Artificial intelligence Pharmacology Medicine Bioinformatics Engineering Biology Internal medicine Geography

Metrics

2
Cited By
2.43
FWCI (Field Weighted Citation Impact)
38
Refs
0.84
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Computational Drug Discovery Methods
Physical Sciences →  Computer Science →  Computational Theory and Mathematics
SARS-CoV-2 and COVID-19 Research
Health Sciences →  Medicine →  Infectious Diseases
Cell Image Analysis Techniques
Life Sciences →  Biochemistry, Genetics and Molecular Biology →  Biophysics

Related Documents

JOURNAL ARTICLE

Computational-based drug repurposing methods in COVID-19

Yosef Masoudi‐Sobhanzadeh

Journal:   Bioimpacts Year: 2020 Vol: 10 (3)Pages: 205-206
JOURNAL ARTICLE

Drug repurposing using computational methods to identify therapeutic options for COVID-19

Soodeh MahdianAzadeh Ebrahim‐HabibiMahboobeh Zarrabi

Journal:   Journal of Diabetes & Metabolic Disorders Year: 2020 Vol: 19 (2)Pages: 691-699
© 2026 ScienceGate Book Chapters — All rights reserved.